查找临床试验
已按「骨髓纤维化」检索，对应国际通用词 myelofibrosis
共找到 12 项正在招募的试验（在欧美日韩等发达国家设有中心）
数据更新于 11:24，每 5 分钟自动同步Phase I/II Clinical Trial of Axatilimab, a CSF1R Monoclonal Antibody, in Combination With Ruxolitinib as Therapy for Patients With Myelofibrosis (MF) and Chronic Myelomonocytic Leukemia (CMML)
United States
年龄 18 Years – 不限
M.D. Anderson Cancer Center
Treating Anemia in Myelofibrosis With Repurposed Drugs (Nelfinavir) That Restore Iron Delivery to the Bone Marrow
United States
年龄 18 Years – 不限
University of California, Irvine
Identification of MPN-specific Antigens and Anti-MPN TCRs in Myeloproliferative Neoplasm
Belgium
年龄 18 Years – 不限
Université Catholique de Louvain
Mutant CALR-peptide Based Vaccine in Patients With Mutated CALR Myeloproliferative Neoplasm
United States
年龄 18 Years – 不限
Marina Kremyanskaya
Maternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing the Safety of Elfabrio® in Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding
United States、Germany、Italy、Spain、United Kingdom
年龄 不限 – 不限
Chiesi Farmaceutici S.p.A.
Two Step Haplo With Radiation Conditioning
United States
年龄 18 Years – 不限
Thomas Jefferson University
A Study of Rebecsinib for Patients With Relapsed/Refractory Secondary Acute Myeloid Leukemia or High Risk Myelofibrosis
United States
年龄 18 Years – 不限
Aspera Biomedicines, Inc.
A Study of Elritercept Alone or Together With Ruxolitinib in Adults With Myelofibrosis
Australia、Brazil、France、Italy、South Korea 等 7 国
年龄 18 Years – 不限
Takeda
Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
United States
年龄 18 Years – 不限
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Momelotinib During and After HCT in Myelofibrosis
United States
年龄 18 Years – 不限
Massachusetts General Hospital
Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
United States、Canada、France、Germany、Italy 等 6 国
年龄 18 Years – 不限
GlaxoSmithKline
A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
United States、Belgium、Bulgaria、Canada、Czechia 等 12 国
年龄 18 Years – 不限
Karyopharm Therapeutics Inc